I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety and immunogenicity of primary vaccination with a SAR..:
Gui-Ling Chen
;
Yuan-Zheng Qiu
;
Kai-Qi Wu
...
https://www.tandfonline.com/doi/10.1080/21645515.2023.2285089. , 2023
Link:
https://doi.org/10.1080/21645515.2023.2285089
RT Journal T1
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trials
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:f56e6467fa8e4f1387547495ab11b508&Exemplar=1&LAN=DE A1 Gui-Ling Chen A1 Yuan-Zheng Qiu A1 Kai-Qi Wu A1 Ying Wu A1 Yuan-Hui Wang A1 Yu-Ying Zou A1 Cong-Gao Peng A1 Jie Zhao A1 Chang Su A1 Jun-Heng Ma A1 Shao-Nan Ni A1 Xing Wang A1 Ting-Han Jin A1 Qi Jiang A1 Tong Guo A1 Yan Xu A1 Chao-Chao Huang A1 Qing Zhang A1 Kai-Li Liu A1 Li Ji A1 Han-Yu Yang A1 Chun-Lei Li A1 Yu-Wen Su A1 Xiang Lu A1 Lan-Juan Li PB Taylor & Francis Group YR 2023 K1 SARS-CoV-2 K1 mRNA vaccine K1 safety K1 immunogenicity K1 clinical trial K1 placebo-controlled K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.tandfonline.com/doi/10.1080/21645515.2023.2285089 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2023.2285089 DO https://doi.org/10.1080/21645515.2023.2285089 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)